Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.
about
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophiliaAntithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunctionAntithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunctionAntithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic ReviewPrevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysisLow-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary eliminationCerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and PreventionLow-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).Coagulation and placenta-mediated complications.Adverse Perinatal Outcome in Subsequent Pregnancy after Stillbirth by Placental Vascular Disorders.Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.Preeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives.Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspectsPrecision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy OutcomeHeparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.Management of inherited thrombophilia in pregnancy.Thrombosis in women: what are the knowledge gaps in 2013?Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation.LMWH to prevent placenta-mediated pregnancy complications: an update.Challenges in cardiology research in pregnancy.Aspirin and heparin in pregnancy.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.The Role of Anticoagulants in the Prevention of Pregnancy Complications.New lenses to look at preeclampsia.Aspirin vs Heparin for the Prevention of Preeclampsia.Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.Effects of low molecular weight heparins and unfractionated heparin on viability of human umbilical vein endothelial cells.Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia.Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampisa associated with fetal growth restriction?Activation of Protein C in Human Trophoblasts in Culture and Downregulation of Trophoblast Endothelial Protein C Receptor by TNF-α.The role of thrombophilia testing in women with adverse pregnancy outcomes
P2860
Q24194917-B85C7EF2-C19A-4E96-AAFA-CEE252BAA8F0Q24201073-D23F9211-9FCF-4D7C-ABB9-8E5355D8CA1CQ24235012-EA30EA4E-6AEB-4482-A509-4BBD2C7F9DF0Q26777548-C6700891-EA10-4C3B-A75F-95D3698700B2Q26781800-01A4D505-A31F-49E4-B3A9-2B15E98E0A2DQ28538906-8E9BC201-A81C-48E1-9DF1-F898A4D0EBD1Q30235534-16A1C97E-093B-4B6D-BB4F-7F6B23EE5EADQ30833556-FDFEDF1D-C067-4C18-935C-06615B6574ECQ34463447-D4C8A3D3-A889-4A82-9E24-C48B628F8B0AQ36030598-496AA3C4-88F9-45C0-9D47-4DFFCA643D28Q36201389-399EBC49-BABF-4FC1-92EE-25E65D685A5DQ36295102-1D8C0C87-92FA-4934-A8F3-30C2DD5EED10Q36927599-B1DA7E3C-D0C7-4A29-840E-202C18D249F4Q37221358-5138603F-0F0B-4A06-A160-06A785282754Q37634740-B28A93FE-895D-48DE-BC27-C79F18DD52C6Q37730086-3A471B30-01AB-40FA-8716-CA2DEB3CE1CAQ38117735-AF864E04-EEDB-4051-BD78-6CABF3FFCA71Q38193203-48FFCAEB-E630-4641-B44B-34CB510E5553Q38206136-39B7C28D-A40E-403D-8E40-D9B77F1DE04CQ38268419-9C6337C1-E0EB-4670-805A-BB0FE631AE1CQ38286290-AEDE05B8-7815-48FF-8EBB-23796D3B9437Q38544097-71FB6B54-739F-4423-AC23-09B5DCDB1780Q38594110-630A2F65-4D01-4923-A1C1-5E8530161B83Q38632931-A04F9CEF-607F-41F1-8A6B-7665E9C45F8EQ38647956-24794FB3-99CC-4A4F-B610-7A60542E766EQ38850828-80A5595C-A7B4-48CA-9481-A182558CBB54Q41699981-7D753821-DAEA-49E0-A305-3178FFF7241EQ47175145-937DEDFA-693B-4800-952C-A7DC9DF75244Q47284780-8C1D1111-C2F1-4CBA-B404-DA76A9B42451Q47419189-95847427-DAF9-4629-BA98-CB07FBDBBAA5Q47436041-941B8705-6CE2-41D5-9873-C3CF2463A522Q51660035-3E27BFF7-EB70-40A3-BFA5-25AC33D21F14Q58205336-86577D41-32F9-4A11-B492-CC6EE627803F
P2860
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Heparin in pregnant women with ...... er, controlled clinical trial.
@ast
Heparin in pregnant women with ...... er, controlled clinical trial.
@en
type
label
Heparin in pregnant women with ...... er, controlled clinical trial.
@ast
Heparin in pregnant women with ...... er, controlled clinical trial.
@en
prefLabel
Heparin in pregnant women with ...... er, controlled clinical trial.
@ast
Heparin in pregnant women with ...... er, controlled clinical trial.
@en
P2093
P2860
P50
P1433
P1476
Heparin in pregnant women with ...... er, controlled clinical trial.
@en
P2093
Barbara Acaia
Giorgio Pardi
Giulia Gherardi
HAPPY Study Group
Maddalena Bozzo
Olimpia Diadei
Sergio Carminati
Stefania Rampello
P2860
P304
P356
10.1182/BLOOD-2011-11-391383
P407
P50
P577
2012-01-30T00:00:00Z